Aakaar Medical Technologies Ltd (AAKAAR) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Aakaar Medical Technologies Ltd on NSE and BSE, with an AI summary of each filing.
Aakaar Medical Technologies Limited has informed the Exchange about the Intimation Of Postal Ballot Notice sent to Shareholders.
Others (Uncategorized) · 04 Nov 2026, 7:01 pm
Aakaar Medical Seeks Shareholder Approval for Executive Appointment and Remuneration Aakaar Medical Technologies issued a postal ballot notice seeking shareholder approval via remote e-voting from 5th Nov'26 to 4th Dec'26 for key leadership resolutions. The company proposed appointing Abhash Dilip Meswani as a Director, Whole-time Director, and Key Managerial Personnel for five years starting 1st Nov'26, alongside his role as Vice President – Xelix. The proposal includes an annual remuneration of ₹50 lakh (~0.75% of FY turnover), performance incentives up to 10% of net profit if EBITDA exceeds ₹15 crore, and related-party transaction approvals.
Aakaar Medical Technologies Limited has informed the Exchange about Transcript
Transcript · 02 Nov 2026, 7:55 pm
Aakaar Medical Technologies Reports Strong H1 FY27 Performance and Operational Turnaround Aakaar Medical Technologies posted revenue from operations of INR43.72 crore for H1 FY27, up 72.64% YoY from INR25.3 crore in Sep'25, with PAT turning around to INR3.54 crore against a loss of INR0.8 crore. EBITDA reached INR5.59 crore with a 12.71% margin, while gross margins stood at 51.39%. Management transitioned to a distributor-led model, appointing over 40 distributors to compress debtor days from 219 days to 130–150 days. The company targets 30%+ revenue CAGR, aiming for mainboard migration within three years.
Aakaar Medical Technologies Limited has informed the Exchange about Link of Recording
Audio / Video · 31 Oct 2026, 1:03 am
Aakaar Medical Technologies Discloses Earnings Call Recording for H1 FY27 Aakaar Medical Technologies Ltd. has uploaded the audio and video recording of its earnings call for the half year ended FY26-27 (H1 FY27) to its corporate website, pursuant to Regulation 30 of SEBI LODR Regulations. The earnings call was conducted on 30th Oct'26 at 4:00 PM. The link to access the recording has been made publicly available on the company's designated disclosures webpage.
Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 31 Oct 2026, 12:06 am
Aakaar Medical Technologies Posts Strong H1FY27 Turnaround; Grants ESOPs Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lakh for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49 lakh. The company turned profitable with a net profit of ₹354.09 lakh compared to a net loss of ₹78.41 lakh in H1FY26, driving basic EPS to ₹2.50 versus negative ₹0.63. Additionally, the board approved granting 186,720 ESOPs at an exercise price of ₹10 and cleared the appointment of Abhash Dilip Meswani as Whole-time Director for five years, subject to shareholder approval.
Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Outcome · 30 Oct 2026, 11:18 pm
Aakaar Medical Technologies Reports Strong H1 FY27 Turnaround; Approves ESOPs and Leadership Addition Aakaar Medical Technologies reported standalone revenue from operations of ₹4,372.34 lacs for the half year ended 30th Sep'26, up 72.65% YoY from ₹2,532.49 lacs. The company turned profitable with a net profit of ₹354.09 lacs compared to a net loss of ₹78.41 lacs on 30th Sep'25, driving basic and diluted EPS to ₹2.50 from negative ₹0.63. Additionally, the board approved granting 186,720 ESOPs at ₹10 face value and appointed Abhash Dilip Meswani as Whole-Time Director and Vice President – Xelix for five years.
Aakaar Medical Technologies Limited has informed the Exchange about Investor Presentation
Press Release · 30 Oct 2026, 9:32 pm
Aakaar Medical Technologies Reports Strong H1 FY27 Performance with 72.6% Revenue Growth Aakaar Medical Technologies reported H1 FY27 revenue from operations of INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26. EBITDA turned positive to INR 5.43 Cr (12.42% margin) versus an EBITDA loss of INR 0.23 Cr. PAT reached INR 3.54 Cr (8.10% margin) compared to a loss of INR 0.78 Cr. Net worth expanded to INR 58.09 Cr. Strategic initiatives include expanding the Xelix doctor-led platform toward 100+ clinics and migrating over 90% of distribution to stockists to reduce debtor days below 130.
Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
Intimation · 30 Oct 2026, 4:00 pm
Aakaar Medical Technologies Schedules H1 FY27 Earnings Call on 30th Oct'26 Aakaar Medical Technologies Limited will host its H1 FY27 earnings conference call on 30th Oct'26 at 4:00 PM IST, hosted by Go India Advisors, following the announcement of half-yearly financial results for the period ended 30th Sep'26. The call will feature Founder & Managing Director Dilip Meswani, CEO & Executive Director Rahul Sawakhande, and CFO Rakesh Parekh to discuss financial performance. Pre-registration is required to access the call.
AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and ESOP.
Intimation · 30 Oct 2026, 5:30 am
Aakaar Medical Technologies Schedules Board Meeting on 30th Oct'26 for Results and ESOP Aakaar Medical Technologies Limited has scheduled a Board of Directors meeting on 30th Oct'26. The board will convene to consider and approve the company's unaudited financial results for the half-year ended Sep'26. Additionally, the agenda includes discussions on the consideration and implementation of an Employee Stock Option Plan (ESOP).
Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
Intimation · 30 Oct 2026, 4:00 pm
Aakaar Medical Technologies Schedules Half-Yearly Earnings Call on 30th Oct'26 Aakaar Medical Technologies Limited will host an earnings conference call on 30th Oct'26 at 4:00 PM IST, hosted by Go India Advisors. The call follows the Board of Directors meeting scheduled earlier the same day to approve the company's unaudited financial results for the half year ended 30th Sep'26. Investors can access the call via universal dial-in (+91 22 7195 0000) or international toll-free numbers across multiple regions.
1. To consider and approve the financial results for the period ended September 30, 2026 2. ESOPs to Employees
Intimation · 30 Oct 2026, 5:30 am
Aakaar Medical Technologies Schedules Board Meeting for H1 FY27 Results and ESOP Allotment Aakaar Medical Technologies Limited announced that its Board of Directors will meet on 30th Oct'26 to consider and approve the unaudited financial results for the half year ended 30th Sep'26. Additionally, the board will evaluate and consider the allotment of Employee Stock Options (ESOPs) to eligible employees based on recommendations from the Nomination and Remuneration Committee.
Aakaar Medical Technologies Limited has informed the Exchange about the Outcome of the Meet.
Others · 16 Sept 2026, 6:01 pm
Aakaar Medical Technologies Concludes Investor Meeting with W.C. Securities Aakaar Medical Technologies Limited concluded a virtual investor meeting with M/s. W.C. Securities on 15th Sep'26 from 3:45 PM to 5:00 PM IST. The company shared general business updates during the interaction. No formal presentation was made, and no unpublished price-sensitive information (UPSI) or material developments were disclosed.
Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
Intimation · 08 Sept 2026, 9:39 pm
Aakaar Medical Technologies Schedules Virtual Investor Meeting on 15th Sep'26 Aakaar Medical Technologies Limited announced that its management will participate in a virtual investor meeting with M/s. W.C. Securities on 15th Sep'26, from 3:45 PM to 5:00 PM IST. The meeting is organized by GoIndia Advisors. The company confirmed that discussions will rely solely on publicly available information, and no unpublished price-sensitive information (UPSI) will be shared.
Aakaar Medical Technologies Limited has informed the Exchange about Outcome
Others · 31 Aug 2026, 10:00 pm
Aakaar Medical Technologies: Outcome of Investor Meeting on GIA Healthcare Day Aakaar Medical Technologies (AAKAAR) met with analysts and investors on 31st Aug'26 at the GIA Healthcare Day event in Mumbai. Participants included KSA Securities, Vaayu Capital, AMBIT, Finterest Capital, Incred Asset Management, Prasad Capital Advisors, Yes Securities, and Stylus. The company confirmed that no presentation was made and no Unpublished Price Sensitive Information (UPSI) was shared during the interactions.
Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
Intimation · 25 Aug 2026, 5:34 pm
Aakaar Medical to Attend GIA Healthcare Day Investor Conference Aakaar Medical Technologies (NSE: AAKAAR) will attend the GIA Healthcare Day on 31st Aug'26. Management will participate in a group conference with investors and analysts from 11:00 AM to 12:30 PM IST at the Jio World Convention Centre, BKC. The event is organized by Go India Advisors. Discussions will be based on publicly available information, with no unpublished price-sensitive information intended to be shared.
Aakaar Medical Technologies Limited has informed the Exchange about the Cancellation Of Investors Meet which was scheduled to be held on 21.08.26
Intimation · 20 Aug 2026, 6:22 pm
Aakaar Medical Technologies Cancels Analyst Meeting Aakaar Medical Technologies (NSE: AAKAAR) has cancelled its scheduled analyst and institutional investor meeting. The meeting was set for 4:00 p.m. on 21st Aug'26. The company cited "unforeseen circumstances" for the cancellation in its exchange filing dated 20th Aug'26. New dates for the meeting will be announced later.
Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet
Intimation · 18 Aug 2026, 8:20 pm
Aakaar Medical Technologies to Attend Investor Meet on Indian Aesthetics Aakaar Medical Technologies (NSE: AAKAAR) management will attend the "Indian Aesthetic Market Meet 2026" with investors and analysts. The virtual meeting, organized by Go India Advisors, is scheduled for Fri, 21st Aug'26, from 4:00 PM to 5:00 PM IST. The company stated that discussions will be based on publicly available information, with no intent to share any unpublished price-sensitive information (UPSI). The meeting is subject to potential changes due to investor or company exigencies.
Aakaar Medical Technologies Limited has informed the Exchange about General Updates
Others (Uncategorized) · 25 Jul 2026, 4:40 am
Aakaar Medical Q1 FY27 Update Highlights Growth Momentum and FY27 Guidance Aakaar Medical Technologies reported strong operational momentum in Q1 FY27, adding 21 new Xelix clinics to reach a total of 28. The company is targeting 100 clinics by H2 FY27 end. Management guided for ~30% revenue growth and ~25% EBITDA growth for FY27. Key initiatives include appointing Novacare as a national CFA partner and expanding its distribution network to 35 distributors across 24 cities. The company also aims to improve debtor days to 120-130 by FY27-end, following its distribution transformation.
Aakaar Medical Technologies Limited has informed the Exchange regarding 'Board Comments on Notice dated 14.07.2026 from National Stock Exchange'.
Others (Uncategorized) · 25 Jul 2026, 4:22 am
Aakaar Medical Responds to NSE Notice on SEBI Regulation Non-Compliance Aakaar Medical Technologies acknowledged a National Stock Exchange notice dated 14th Jul'26, which alleged non-compliance with SEBI Regulation 44(3). At its meeting on 24th Jul'26, the Board of Directors stated the non-compliance was inadvertent and procedural. Management has implemented corrective and preventive measures to ensure strict and timely compliance with SEBI Listing Obligations and Disclosure Requirements going forward. The company has filed this response with the exchange for record-keeping.
Aakaar Medical Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Jul 2026, 12:16 am
Aakaar Medical Technologies Limited has informed the Exchange regarding Change in Auditors of the company.
Change in Auditor · 30 Jun 2026, 11:04 pm
Aakaar Medical Technologies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Others (Uncategorized) · 30 Jun 2026, 11:01 pm
Aakaar Medical Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on Jun 30, 2026
Annual General Meeting · 30 Jun 2026, 10:57 pm